- Bombshell development in the wearables market as Nike bows out (well, of the hardware side, anyway), putting the brakes on future Fuelband iterations amid speculation that they're clearing the way for a collaboration with Apple.
- A trio large pharmas traded units amid continued emphasis on narrowly focused portfolios. Novartis bought a pair of GSK cancer drugs to complement its Gleevec franchise, and in turn sold its vaccines business to GSK while also selling its animal health division to Lilly.
- For all the payer gnashing of teeth over Gilead's pricey hep C drug Sovaldi, so far, it's not crimping sales. The brand crushed analysts expectations for $1.13 billion in sales by more than a billion. However, several medical societies are starting to factor costs into treatment guidelines or are threatening to, anyway.
- There's now a whole medical scribe staffing industry to help physicians feed their EHRs in patient consults.
- Is Facebook dipping a toe in the fitness tracking market with its latest purchase?
- The comments period for FDA's first draft guidance on social media closed, and Klick Health has an overview of the comments. The sore spots are the definitions of editorial control and influence.
- Nine out of ten Americans are willing to share their health data with researchers, but for most, it's conditional, and data privacy is a concern.
- Apple is embracing digital advertising in a big way for the first time after pursuing a TV-centric advertising strategy for its entire existence. Wait, what Who says pharma's an old fuddy-duddy of an industry, anyway?
- - See more at: http://healthandpharmainsight.tumblr.com/post/83842375761/in-case-you-missed-it#sthash.AjKFLjGO.dpuf
By Matthew Arnold, Principal Analyst
The proliferation of physician ratings sites is one aspect of the growing consumerization of healthcare in the U.S., and websites like Vitals and Healthgrades have the attention of doctors, The Wall Street Journal reports:
Many doctors remain wary of online reviews, concerned that negative comments can damage their reputation. Being a good doctor can sometimes mean giving patients hard advice. And some doctors fear comments from disgruntled patients or ex-employees could drive other patients away.
Some reviews can be pretty brutal, says Andrew Pasternak, a family physician in Reno, Nev. However, he says, part of being a physician now is having to deal with these.
Indeed, according to Manhattan Research data from 2013, more than a quarter of U.S. consumers had accessed or posted ratings or reviews of healthcare providers, hospitals or products over the previous year. Throw cost transparency tools like Castlight into the mix, and you can see consumers getting much more comfortable comparison-shopping online for healthcare products and services much as they would a pair of chinos or a new laptop. For many physicians, this probably seems like one more little ding against their professional stature and authority, but it's not all bad:
Some reviews are constructive. When a patient noted on an online site that Dr. Pasternak was spending too much time jotting notes on his tablet computer, he says he made an effort to make better eye contact and appear more attentive.
For all parties in the healthcare industry, it's a time of greater accountability to payers and, increasingly, to consumers fueled by policy and technology.